Replies to post #23 on Telomir Pharmaceuticals Inc (TELO)

[Monroe1]

I love Telomir too!! This is quite something.
09:31 AM EDT, 03/19/2025 (MT Newswires) -- Telomir Pharmaceuticals ( TELO ) said Wednesday that preclinical findings showed that Telomir-1 reduces tumor size by 50% in a prostate cancer animal model using "highly aggressive" human prostate cancer cells.

Telomir-1 "actively suppresses cancer growth rather than promoting it, and protects against chemotherapy-induced toxicity and mortality when combined with Paclitaxel," a chemotherapy drug that is often linked with severe toxicity and side effects, the company said.

Telomir said it is advancing Telomir-1 in several indications in addition to oncology. Studies are assessing the drug in age-related diseases like age-related macular degeneration and Wilson's disease, the company said.

The company said it plans to file an investigational new drug application by the end of the year.